Preoperative Serum Cortisol Level Is Predictive of Weight Loss After Laparoscopic Sleeve Gastrectomy in Men with Severe Obesity but Not Women.


Journal

Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714

Informations de publication

Date de publication:
03 2023
Historique:
received: 29 03 2022
accepted: 09 12 2022
revised: 30 11 2022
pubmed: 11 1 2023
medline: 9 3 2023
entrez: 10 1 2023
Statut: ppublish

Résumé

Bariatric surgery is an effective treatment for severe obesity and its associated medical problems. Preoperative factors that predict postoperative weight loss remain to be fully characterized, however. Anthropometric and laboratory data were collected retrospectively for severely obese patients who underwent laparoscopic sleeve gastrectomy (LSG) between April 2016 and July 2019 at our hospital. Preoperative factors that predicted weight loss at 1 year after LSG were investigated. A total of 122 subjects (45 men and 77 women) underwent LSG. The mean ± SD age and body mass index at surgery were 44.4 ± 10.4 years and 40.7 ± 6.7 kg/m Serum cortisol concentration was identified as a predictor for postoperative weight loss in men. Our results may thus help inform the decision to perform LSG or more effective surgical procedures in men with severe obesity.

Sections du résumé

BACKGROUND
Bariatric surgery is an effective treatment for severe obesity and its associated medical problems. Preoperative factors that predict postoperative weight loss remain to be fully characterized, however.
METHODS
Anthropometric and laboratory data were collected retrospectively for severely obese patients who underwent laparoscopic sleeve gastrectomy (LSG) between April 2016 and July 2019 at our hospital. Preoperative factors that predicted weight loss at 1 year after LSG were investigated.
RESULTS
A total of 122 subjects (45 men and 77 women) underwent LSG. The mean ± SD age and body mass index at surgery were 44.4 ± 10.4 years and 40.7 ± 6.7 kg/m
CONCLUSIONS
Serum cortisol concentration was identified as a predictor for postoperative weight loss in men. Our results may thus help inform the decision to perform LSG or more effective surgical procedures in men with severe obesity.

Identifiants

pubmed: 36626105
doi: 10.1007/s11695-022-06415-z
pii: 10.1007/s11695-022-06415-z
pmc: PMC9988780
doi:

Substances chimiques

Hydrocortisone WI4X0X7BPJ

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

851-859

Informations de copyright

© 2023. The Author(s).

Références

Haslam DW, James WP. Obesity. Lancet. 2005;366:1197–209.
doi: 10.1016/S0140-6736(05)67483-1 pubmed: 16198769
Gloy VL, Briel M, Bhatt DL, Kashyap SR, Schauer PR, Mingrone G, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f5934.
doi: 10.1136/bmj.f5934 pubmed: 24149519 pmcid: 3806364
Bray GA, Frühbeck G, Ryan DH, Wilding JP. Management of obesity. Lancet. 2016;387:1947–56.
doi: 10.1016/S0140-6736(16)00271-3 pubmed: 26868660
Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, et al. Bariatric surgery versus intensive medical therapy for diabetes-5-year outcomes. N Engl J Med. 2017;376:641–51.
doi: 10.1056/NEJMoa1600869 pubmed: 28199805 pmcid: 5451258
Angrisani L, Santonicola A, Iovino P, Formisano G, Buchwald H, Scopinaro N. Bariatric surgery worldwide 2013. Obes Surg. 2015;25:1822–32.
doi: 10.1007/s11695-015-1657-z pubmed: 25835983
Angrisani L, Santonicola A, Iovino P, Ramos A, Shikora S, Kow L. Bariatric surgery survey 2018: similarities and disparities among the 5 IFSO chapters. Obes Surg. 2021;31:1937–48.
doi: 10.1007/s11695-020-05207-7 pubmed: 33432483 pmcid: 7800839
Rosenthal RJ, Diaz AA, Arvidsson D, Baker RS, Basso N, Bellanger D, et al. International sleeve gastrectomy expert panel consensus statement: best practice guidelines based on experience of >12,000 cases. Surg Obes Relat Dis. 2012;8:8–19.
doi: 10.1016/j.soard.2011.10.019 pubmed: 22248433
Dixon JB, Dixon ME, O’Brien PE. Pre-operative predictors of weight loss at 1-year after Lap-Band surgery. Obes Surg. 2001;11:200–7.
doi: 10.1381/096089201321577884 pubmed: 11355027
Ma Y, Pagoto SL, Olendzki BC, Hafner AR, Perugini RA, Mason R, et al. Predictors of weight status following laparoscopic gastric bypass. Obes Surg. 2006;16:1227–31.
doi: 10.1381/096089206778392284 pubmed: 16989709
Saboor Aftab SA, Halder L, Piya MK, Reddy N, Fraser I, Menon V, et al. Predictors of weight loss at 1 year after laparoscopic adjustable gastric banding and the role of presurgical quality of life. Obes Surg. 2014;24:885–90.
doi: 10.1007/s11695-014-1184-3 pubmed: 24442423
Al-Khyatt W, Ryall R, Leeder P, Ahmed J, Awad S. Predictors of inadequate weight loss after laparoscopic gastric bypass for morbid obesity. Obes Surg. 2017;27:1446–52.
doi: 10.1007/s11695-016-2500-x pubmed: 27943095
Nickel F, de la Garza JR, Werthmann FS, Benner L, Tapking C, Karadza E, et al. Predictors of risk and success of obesity surgery. Obes Facts. 2019;12:427–39.
doi: 10.1159/000496939 pubmed: 31416073 pmcid: 6758709
Ohira M, Watanabe Y, Yamaguchi T, Saiki A, Oshiro T, Tatsuno I. Low serum insulin-like growth factor-1 level is a predictor of low total weight loss percentage after sleeve gastrectomy. Surg Obes Relat Dis. 2020;16:1978–87.
doi: 10.1016/j.soard.2020.07.033 pubmed: 32900619
Sisik A, Basak F. Presurgical predictive factors of excess weight loss after laparoscopic sleeve gastrectomy. Obes Surg. 2020;30:2905–12.
doi: 10.1007/s11695-020-04624-y pubmed: 32307671
Hattori K, Numata N, Ikoma M, Matsuzaka A, Danielson RR. Sex differences in the distribution of subcutaneous and internal fat. Hum Biol. 1991;63:53–63.
pubmed: 2004744
Ohta M, Kasama K, Sasaki A, Naitoh T, Seki Y, Inamine S, et al. Current status of laparoscopic bariatric/metabolic surgery in Japan: the sixth nationwide survey by the Japan Consortium of Obesity and Metabolic Surgery. Asian J Endosc Surg. 2021;14:170–7.
doi: 10.1111/ases.12836 pubmed: 32696619
Ma RC, Chan JC. Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States. Ann N Y Acad Sci. 2013;1281:64–91.
doi: 10.1111/nyas.12098 pubmed: 23551121 pmcid: 3708105
Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E, et al. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Investig. 2010;1:212–28.
doi: 10.1111/j.2040-1124.2010.00074.x pubmed: 24843435 pmcid: 4020724
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39:412–23.
doi: 10.1093/ageing/afq034 pubmed: 20392703 pmcid: 2886201
Sun YQ, Burgess S, Staley JR, Wood AM, Bell S, Kaptoge SK, et al. Body mass index and all cause mortality in HUNT and UK Biobank studies: linear and non-linear mendelian randomisation analyses. BMJ. 2019;364:1042.
doi: 10.1136/bmj.l1042
Zurlo F, Larson K, Bogardus C, Ravussin E. Skeletal muscle metabolism is a major determinant of resting energy expenditure. J Clin Invest. 1990;86:1423–7.
doi: 10.1172/JCI114857 pubmed: 2243122 pmcid: 296885
Wing RR, Marcus MD, Epstein LH, Salata R. Type II diabetic subjects lose less weight than their overweight nondiabetic spouses. Diabetes Care. 1987;10:563–6.
doi: 10.2337/diacare.10.5.563 pubmed: 3677974
Cadena-Obando D, Ramírez-Rentería C, Ferreira-Hermosillo A, Albarrán-Sanchez A, Sosa-Eroza E, Molina-Ayala M, et al. Are there really any predictive factors for a successful weight loss after bariatric surgery? BMC Endocr Disord. 2020;20:20.
doi: 10.1186/s12902-020-0499-4 pubmed: 32024495 pmcid: 7003414
Tataranni PA, Larson DE, Snitker S, Young JB, Flatt JP, Ravussin E. Effects of glucocorticoids on energy metabolism and food intake in humans. Am J Physiol. 1996;271:E317–25.
pubmed: 8770026
Kaess BM, Pedley A, Massaro JM, Murabito J, Hoffmann U, Fox CS. The ratio of visceral to subcutaneous fat, a metric of body fat distribution, is a unique correlate of cardiometabolic risk. Diabetologia. 2012;55:2622–30.
doi: 10.1007/s00125-012-2639-5 pubmed: 22898763 pmcid: 3636065
Vennapusa A, Panchangam RB, Kesara C, Chivukula T. Factors predicting weight loss after “sleeve gastrectomy with loop duodenojejunal bypass” surgery for obesity. J Obes Metab Syndr. 2020;29:208–14.
doi: 10.7570/jomes20044 pubmed: 32908024 pmcid: 7539344
Tu Y, Pan Y, Han J, Pan J, Zhang P, Jia W, et al. A total weight loss of 25% shows better predictivity in evaluating the efficiency of bariatric surgery. Int J Obes (Lond). 2021;45:396–403.
doi: 10.1038/s41366-020-00690-5 pubmed: 32981929
Cobey F, Leone L, Taliaferro I. Effect of diethylstilbestrol on plasma 17-hydroxycorticosteroid levels in humans. Proc Soc Exp Biol Med. 1956;92:742–4.
doi: 10.3181/00379727-92-22599 pubmed: 13370513
Himeno A, Satoh-Asahara N, Usui T, Wada H, Tochiya M, Kono S, et al. Salivary cortisol levels are associated with outcomes of weight reduction therapy in obese Japanese patients. Metab. 2012;61:255–61.
doi: 10.1016/j.metabol.2011.06.023
Ma L, Liu X, Yan N, Gan Y, Wu Y, Li Y, et al. Associations between different cortisol measures and adiposity in children: a systematic review and meta-analysis. Front Nutr. 2022;9:879256.
doi: 10.3389/fnut.2022.879256 pubmed: 35811977 pmcid: 9260431
Vermeulen A, Kaufman JM, Deslypere JP, Thomas G. Attenuated luteinizing hormone (LH) pulse amplitude but normal LH pulse frequency, and its relation to plasma androgens in hypogonadism of obese men. J Clin Endocrinol Metab. 1993;76:1140–6.
pubmed: 8496304
Kelly DM, Jones TH. Testosterone and obesity. Obes Rev. 2015;16:581–606.
doi: 10.1111/obr.12282 pubmed: 25982085
Mah PM, Wittert GA. Obesity and testicular function. Mol Cell Endocrinol. 2010;316:180–6.
doi: 10.1016/j.mce.2009.06.007 pubmed: 19540307
Bambino TH, Hsueh AJ. Direct inhibitory effect of glucocorticoids upon testicular luteinizing hormone receptor and steroidogenesis in vivo and in vitro. Endocrinol. 1981;108:2142–8.
doi: 10.1210/endo-108-6-2142
Cumming DC, Quigley ME, Yen SS. Acute suppression of circulating testosterone levels by cortisol in men. J Clin Endocrinol Metab. 1983;57:671–3.
doi: 10.1210/jcem-57-3-671 pubmed: 6348068
Kelly DM, Jones TH. Testosterone: a metabolic hormone in health and disease. J Endocrinol. 2013;217:R25-45.
doi: 10.1530/JOE-12-0455 pubmed: 23378050
Hodish I. Insulin therapy, weight gain and prognosis. Diabetes Obes Metab. 2018;20:2085–92.
doi: 10.1111/dom.13367 pubmed: 29785843
Biertho L, Lebel S, Marceau S, Hould FS, Lescelleur O, Marceau P, et al. Laparoscopic sleeve gastrectomy: with or without duodenal switch? A consecutive series of 800 cases. Dig Surg. 2014;31:48–54.
doi: 10.1159/000354313 pubmed: 24819497
Shimon O, Keidar A, Orgad R, Yemini R, Carmeli I. Long-term effectiveness of laparoscopic conversion of sleeve gastrectomy to a biliopancreatic diversion with a duodenal switch or a Roux-en-Y gastric bypass due to weight loss failure. Obes Surg. 2018;28:1724–30.
doi: 10.1007/s11695-017-3086-7 pubmed: 29374818

Auteurs

Hironori Bando (H)

Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.

Hiroshi Miura (H)

Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.

Seiichi Kitahama (S)

Department of Metabolic and Bariatric Surgery, Center for Obesity, Diabetes, and Endocrinology, Chibune General Hospital, Osaka, Japan.

Shinsuke Nakajima (S)

Department of Diabetes and Endocrinology, Center for Obesity, Diabetes, and Endocrinology, Chibune General Hospital, Osaka, Japan.

Tetsuya Takahashi (T)

Department of Diabetes and Endocrinology, Center for Obesity, Diabetes, and Endocrinology, Chibune General Hospital, Osaka, Japan.

Toshihiko Mihara (T)

Department of General Surgery, Chibune General Hospital, Osaka, Japan.

Teppei Momono (T)

Department of General Surgery, Chibune General Hospital, Osaka, Japan.

Maki Kimura-Koyanagi (M)

Division of Medical Education, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.

Kazuhiko Sakaguchi (K)

Division of General Internal Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.

Tomoichiro Mukai (T)

Department of General Surgery, Chibune General Hospital, Osaka, Japan.

Wataru Ogawa (W)

Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.

Yoshikazu Tamori (Y)

Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan. tamori@med.kobe-u.ac.jp.
Division of Creative Health Promotion, Department of Social/Community Medicine and Health Science, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-Cho, Chuo-Ku, Kobe, 650-0017, Japan. tamori@med.kobe-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH